STIGATIONAL NEW DRUG APPLICATION (IND) NOTE: No drug/biologic may be shipped or clinical investigation begun until an IND for that investigation is in effect (21 CFR 312.40) (Title 21, Code of Federal Regulations (CFR) Part 312) 1. Name of Sponsor 2. Date of Submission (mm/dd/yyyy) 4. Telephone Number (Include country code if applicable and area code) 3. Sponsor Address Address 1 (Street address, P.O. box, company name c/o) Address 2 (Apartment, suite, unit, building, floor, etc.) City 6A.
Loading
Open form follow the instructions
Easily sign the form with your finger
Send filled & signed form or save
How to fill out the FDA 1571 online
Filing an Investigational New Drug Application (IND) using Form FDA 1571 is a crucial step in the clinical investigation process. This guide provides clear and comprehensive instructions on how to complete the FDA 1571 form online, ensuring that you efficiently address each required section.
Follow the steps to fill out the FDA 1571 effectively.
- Click ‘Get Form’ button to obtain the form and open it in your preferred editor.
- Begin with section 1, entering the name of the sponsor accurately. This is the individual or organization responsible for the drug application.
- In section 2, input the submission date using the format mm/dd/yyyy. Ensure this date is accurate as it may be referenced in future communications.
- Section 3 requires the sponsor's address. Fill in the address fields completely, including address 1, address 2 (if applicable), city, state/province/region, country, and ZIP or postal code.
- Section 4 asks for a telephone number, including the country code and area code if applicable. Make sure the number is up to date for any follow-ups.
- In section 5, provide the drug name, including all available names such as trade, generic, and chemical. If there are additional names, use the continuation page.
- Section 6A requests the IND number if one has been previously assigned. If this is a new application, you may leave this blank.
- For section 6B, indicate whether the submission is for a commercial or research purpose by selecting one of the options provided.
- In section 7A, state the proposed indication for use of the drug. If applicable, address whether this indication is for a rare disease.
- Section 7B requests the SNOMED CT indication disease term. If there are additional indications, continue on a separate page.
- Indicate the phase of clinical investigation you will conduct in section 8. This could be Phase 1, Phase 2, Phase 3, or another phase, which should be specified.
- Section 9 requires a list of all previously submitted Investigational New Drug Applications, New Drug Applications, Drug Master Files, and Biologics License Applications referred to in this application.
- Assign a serial number for this submission in section 10, starting with ‘Serial Number: 0000’ for the initial submission.
- In section 11, select all relevant items that apply to this submission, such as Initial IND, Annual Report, or other specified options.
- Section 12 asks if the product is a combination product and requires an answer to facilitate regulatory compliance.
- In section 15, indicate if any part of the clinical study will be conducted by a contract research organization, and disclose any obligations transferred.
- Sections 16 and 17 require names and titles of responsible persons monitoring the investigations and evaluating safety information.
- Provide your name and title in section 18 and complete the contact details including the email address for correspondence.
- In section 23, enter the date of the sponsor’s signature using the mm/dd/yyyy format.
- Complete any required sections for the countersigner if applicable and ensure all signatures are provided where requested.
- Lastly, review all entries for accuracy and completeness. Once done, you can save changes, download the form, print it for records, or share it as needed.
Complete your FDA 1571 form online today to ensure a smooth submission process.
Experience a faster way to fill out and sign forms on the web. Access the most extensive library of templates available.
Related content
Sep 7, 2023 — FDA has revised form 356h: Application to Market a New or Abbreviated New...
Form FDA 1571. Completed by the IND Sponsor and must be included on all submissions made...
Form FDA 1571 or Form FDA 356h ... Form FDA 1571 or Form FDA 356h. 94. 95. All electronic...
Get answers to your most pressing questions about US Legal Forms API.
What is the purpose of the 1572 form?
The purpose of the 1572 form is to document the qualifications of the clinical investigator and the details of the clinical trial site. This form ensures that the investigator is well-equipped to conduct the trial in compliance with regulatory standards. Additionally, it reinforces USA regulations on the conduct of clinical studies by ensuring that proper oversight is maintained. Submitting a thorough 1572 form strengthens the overall integrity of the research.
Who submits form FDA 1572?
Form FDA 1572 is typically submitted by the clinical investigator responsible for conducting the trial. This form serves to provide the FDA with information about the investigator's qualifications, the site of the study, and the trial's design. It acts as an essential companion to Form 1571 and helps establish the integrity of the clinical trial process. Understanding the roles and responsibilities outlined in these forms is crucial for smooth project execution.
When should the FDA form 1571 be used?
FDA Form 1571 should be used whenever a sponsor intends to initiate a clinical trial for an investigational drug. This includes any phase of clinical research, from early safety assessments to late-stage efficacy trials. It marks the formal beginning of an investigation into a new medication, ensuring that the FDA is fully informed. By filing Form 1571 appropriately, sponsors can facilitate transparency and collaboration with the FDA.
What is Form 1571 in clinical research?
Form 1571 is a vital document in the clinical research arena that outlines an investigator's plans to conduct clinical trials for a new drug. This form gathers comprehensive information about the study, including treatment protocols and participant safety measures. Proper completion of Form 1571 is essential for receiving FDA endorsement and advancing research efforts. By using this form effectively, researchers can communicate their intentions efficiently to the FDA.
How do I submit FDA approval?
To submit for FDA approval, you must compile all necessary documentation, including FDA Form 1571, and follow the guidelines provided by the FDA. The submission can be made electronically using the FDA's eSubmitter software or through traditional mail, depending on specific requirements. It is vital to ensure that all forms are filled out accurately to avoid delays in your approval process. Utilizing platforms like USLegalForms can help simplify the preparation and submission of these documents.
What is the purpose of the FDA form 1571?
The FDA Form 1571 serves as the official application form for sponsors to request an IND. This form collects essential information about the drug, including its proposed indications, preclinical research, and clinical trial details. By submitting Form 1571, sponsors provide the FDA with necessary information to evaluate the safety and effectiveness of the new drug. It is a critical step in initiating clinical trials.
How many days does the FDA have to respond to a request from an investigator sponsor for an IND?
The FDA has a 30-day review period to respond to an investigator sponsor's request for an Investigational New Drug application, or IND. During this time, the agency evaluates the submitted information to ensure the safety of study participants. If the FDA does not respond within this period, the sponsor may proceed with the trial. This timeline is crucial for maintaining research momentum in the drug development process.
How do I submit documents to the FDA?
Submitting documents to the FDA can be done electronically or via postal service, depending on the type of submission. For most applications, including those that require FDA 1571, electronic submissions are highly encouraged to expedite the process. Always ensure that your documents are complete and clearly labeled to facilitate a smooth submission.
How do I file a report with the FDA?
Filing a report with the FDA involves identifying the type of report you need to submit and gathering relevant information. You can often do this online or through specific forms, like the FDA 1571, depending on the nature of the report. Clear and accurate reporting helps the FDA maintain product safety and effectiveness across various markets.
How do I report suspicious activity to the FDA?
To report suspicious activity to the FDA, you can use the agency's online reporting system or contact them directly via phone. Providing specific details about the suspicious behavior enhances the investigation process. In some cases, the information provided may necessitate completing an FDA 1571 to ensure proper documentation and follow-up.
Use professional pre-built templates to fill in and sign documents online faster. Get access to thousands of forms.
If you believe that this page should be taken down, please follow our DMCA take down process here.